首页> 外文期刊>Respiration: International Review of Thoracic Diseases >Ineffectiveness of intravenous beta 2-agonists on improving exercise tolerance in patients with reversible chronic airway obstruction.
【24h】

Ineffectiveness of intravenous beta 2-agonists on improving exercise tolerance in patients with reversible chronic airway obstruction.

机译:静脉内β2受体激动剂对改善可逆性慢性气道阻塞患者运动耐力的作用无效。

获取原文
获取原文并翻译 | 示例
       

摘要

The effects on exercise tolerance after acute administration of beta 2-agonists were investigated in 11 patients with partly reversible chronic airway obstruction after 400 micrograms of salbutamol (S) given intravenously (i.v.) and after 400 micrograms i.v. of a new selective beta 2-agonist, broxaterol (B), by a cardiopulmonary incremental exercise test. At rest, while VE increased in respect to basal conditions (C) after S (from 13.3 +/- 2.2 to 14.4 +/- 2.8 l/min; p < 0.05) and after B (from 13.6 +/- 3.1 to 15.5 +/- 3.6 l/min; p < 0.05), VO2, VCO2 and VO2/HR showed no substantial variations. A small, not significant reduction of PaO2 was observed both after S (from 82.7 +/- 11.7 to 79.1 +/- 16.7 mm Hg) and B (from 81.6 +/- 10.5 to 78.0 +/- 11.0 mm Hg). The maximum workload increased neither after S (from 67.5 +/- 39.1 to 66.6 +/- 37.0 W) nor after B (from 65.7 +/- 39.3 to 60.0 +/- 35.8 W). At peak of exercise, VO2, VCO2 and VO2/HR did not change after S and B as compared with C, whereas VE remained higher after both beta 2-agonists throughout the effort. VO2 at ventilatory anaerobic threshold (AT) was significantly greater either after S (from 744 +/- 378 to 815 +/- 302 ml/min; p < 0.05) and after B (from 756 +/- 290 to 842 +/- 292 ml/min; p < 0.05). The PaO2 increase shown by these patients during effort was greater after beta 2-agonists administration, delta PaO2 from rest to peak of exercise amounting to 14.9 +/- 14.3 vs. 7.8 +/- 8.2 mm Hg after S and to 17.8 +/- 15.1 vs. 8.8 +/- 10.9 mm Hg after B, in respect to relative baseline (p < 0.05). We conclude that beta 2-agonists, when given acutely, do not improve exercise tolerance in patients with reversible chronic airflow obstruction, although these drugs can induce a small increment of ventilatory AT. In addition, arterial blood gases do not deteriorate at rest and are better preserved during exercise after beta 2-agonists.
机译:在11例经静脉(i.v.)静脉给予400毫克沙丁胺醇(S)和400毫克静脉内给予沙丁胺醇(S)的部分可逆性慢性气道阻塞患者中,研究了急性给予β2受体激动剂后运动耐力的影响。心肺增量运动试验测定一种新的选择性β2激动剂溴沙特罗(B)。静止时,相对于基础条件(C),VE在S后(从13.3 +/- 2.2增至14.4 +/- 2.8 l / min; p <0.05)和在B之后(从13.6 +/- 3.1增至15.5 + /-3.6 l / min; p <0.05),VO2,VCO2和VO2 / HR没有实质性变化。在S(从82.7 +/- 11.7毫米汞柱到79.1 +/- 16.7毫米汞柱)和B(从81.6 +/- 10.5毫米汞柱到78.0 +/- 11.0毫米汞柱)之后均观察到PaO2的少量但不显着降低。 S之后(从67.5 +/- 39.1 W到66.6 +/- 37.0 W)和B之后(从65.7 +/- 39.3 W到60.0 +/- 35.8 W),最大工作负载都没有增加。在运动的高峰期,S和B后的VO2,VCO2和VO2 / HR与C相比没有变化,而在整个努力过程中,两个β2激动剂后VE仍然较高。在S后(从744 +/- 378至815 +/- 302 ml / min; p <0.05)和B后(从756 +/- 290至842 +/-),通气无氧阈值(AT)的VO2明显更高292毫升/分钟; p <0.05)。这些患者在努力期间显示的PaO2增加在使用β2受体激动剂后更大,从静止到运动高峰的PaO2增量为14.9 +/- 14.3 vs. S后为7.8 +/- 8.2 mm Hg,达到17.8 +/- B后相对于相对基线(15.1 vs.8.8 +/- 10.9 mm Hg)(p <0.05)。我们得出的结论是,当急性给予β2受体激动剂时,可逆性慢性气流阻塞患者不能提高运动耐受性,尽管这些药物可引起通气性AT的少量增加。此外,β2受体激动剂运动后,动脉血气在休息时不会变质,可以更好地保存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号